Brain/CNS Clinical Trials
Narrow List by Age:
(Refer to Clinical Summary for age requirements)
Brain/CNS
| Protocol | NRG BN011 |
|---|---|
| Cancer Type: | Methylated MGMT Promoter Glioblastoma |
| Fast Facts |
A Phase III Trial of Lomustine-Temozolomide Combination Therapy Versus Standard Temozolomide in Patients with Methylated MGMT Promoter Glioblastoma
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | Alliance A071401 |
|---|---|
| Cancer Type: | MENINGIOMAS WITH SMO/AKT/NF2 MUTATIONS |
| Fast Facts |
PHASE II TRIAL OF SMO/AKT/NF2/CDK INHIBITORS IN PROGRESSIVE MENINGIOMAS WITH SMO/AKT/NF2/CDK PATHWAY MUTATIONS
| Protocol | NRG BN003 |
|---|---|
| Cancer Type: | MENINGIOMA |
| Fast Facts |
Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | Alliance A071701 |
|---|---|
| Cancer Type: | Brain metastases |
| Fast Facts |
Genomically-Guided Treatment Trial in Brain Metastases
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | COG ACNS2021 |
|---|---|
| Cancer Type: | CNS - Germ Cell |
| Fast Facts |
COG ACNS2021
A Phase 2 Trial of Chemotherapy followed by Response-Based Whole Ventricular & Spinal Canal Irradiation (WVSCI) for Patients with Localized Non-Germinomatous Central Nervous System Germ Cell Tumor
Patients must be greater than or equal to 3 years and less than 30 years at the time of study enrollment.
| Protocol | COG ACNS2031 |
|---|---|
| Cancer Type: | Medulloblastoma |
| Fast Facts |
COG-ACNS2031: A Phase 3 Study of Sodium Thiosulfate for the Reduction of Cisplatin-Induced Ototoxicity in Children with Average-Risk Medulloblastoma and Reduced Therapy for Children with Medulloblastoma with Low-Risk Features
Age: ≥ 4 years and ≤ 21 years of age at the time of enrollment
| Protocol | COG ACNS2321 |
|---|---|
| Cancer Type: | CNS |
| Fast Facts |
A Phase II Trial Evaluating Chemotherapy followed by Response-Based Reduced Radiation Therapy for Patients with Central Nervous System Germinomas
Patients must be ≥ 3 years and < 30 years at the time of enrollment on screening.
Please check out the rare protocol list to locate other studies within this disease site.
Cancer clinical trials are research studies for developing better ways of detecting,
treating, and eventually preventing cancer. By taking part in a clinical trial,
you are among the first to receive new research treatments before they are widely
available. Your participation in a clinical trial will influence the future direction
of cancer care.
If you are interested in participating in a clinical trial, consult with your physician.
Please note: clinical trials are not risk free. Patients must explore the options
that are best for their individuals needs with the help of their physician.
